Molecular Docking and Binding Mode Analysis of Plant Alkaloids as in vitro and in silico Inhibitors of Trypanothione Reductase from Trypanosoma cruzi
- PMID: 26996020
Molecular Docking and Binding Mode Analysis of Plant Alkaloids as in vitro and in silico Inhibitors of Trypanothione Reductase from Trypanosoma cruzi
Abstract
Trypanothione reductase (TryR) is a key enzyme in the metabolism of Trypanosoma cruzi, the parasite responsible for Chagas disease. The available repertoire of TryR inhibitors relies heavily on synthetic substrates of limited structural diversity, and less on plant-derived natural products. In this study, a molecular docking procedure using a Lamarckian Genetic Algorithm was implemented to examine the protein-ligand binding interactions of strong in vitro inhibitors for which no X-ray data is available. In addition, a small, skeletally diverse, set of natural alkaloids was assessed computationally against T. cruzi TryR in search of new scaffolds for lead development. The preferential binding mode (low number of clusters, high cluster population), together with the deduced binding interactions were used to discriminate among the virtual inhibitors. This study confirms the prior in vitro data and proposes quebrachamine, cephalotaxine, cryptolepine, (22S,25S)-tomatidine, (22R,25S)-solanidine, and (22R,25R)-solasodine as new alkaloid scaffold leads in the search for more potent and selective TryR inhibitors.
Similar articles
-
Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.Mol Divers. 2017 Aug;21(3):697-711. doi: 10.1007/s11030-017-9747-6. Epub 2017 Jun 27. Mol Divers. 2017. PMID: 28656524
-
The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors.Bioorg Med Chem. 2008 Jul 15;16(14):6689-95. doi: 10.1016/j.bmc.2008.05.074. Epub 2008 Jun 2. Bioorg Med Chem. 2008. PMID: 18558492
-
Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.J Med Chem. 1998 Jan 15;41(2):148-56. doi: 10.1021/jm960814j. J Med Chem. 1998. PMID: 9457238
-
Parasite-specific trypanothione reductase as a drug _target molecule.Parasitol Res. 2003 Jun;90 Suppl 2:S77-85. doi: 10.1007/s00436-002-0771-8. Epub 2003 Apr 23. Parasitol Res. 2003. PMID: 12709793 Review.
-
Trypanothione reductase inhibitors: Overview of the action of thioridazine in different stages of Chagas disease.Acta Trop. 2015 May;145:79-87. doi: 10.1016/j.actatropica.2015.02.012. Epub 2015 Feb 27. Acta Trop. 2015. PMID: 25733492 Review.
Cited by
-
Recent Advances in the Chemistry and Pharmacology of Cryptolepine.Prog Chem Org Nat Prod. 2021;115:177-203. doi: 10.1007/978-3-030-64853-4_4. Prog Chem Org Nat Prod. 2021. PMID: 33797643
-
The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.Molecules. 2016 Oct 19;21(10):1389. doi: 10.3390/molecules21101389. Molecules. 2016. PMID: 27775577 Free PMC article. Review.
-
Glycoalkaloids of Plants in the Family Solanaceae (Nightshade) as Potential Drugs.Pharm Chem J. 2022;56(7):948-957. doi: 10.1007/s11094-022-02731-x. Epub 2022 Oct 18. Pharm Chem J. 2022. PMID: 36277854 Free PMC article.
-
Clarifying the Configuration of Pandamine by an Extensive Spectroscopic Reinvestigation of the Authentic 1964 Sample.Metabolites. 2023 Mar 24;13(4):470. doi: 10.3390/metabo13040470. Metabolites. 2023. PMID: 37110129 Free PMC article.
-
Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs.Molecules. 2021 Jun 22;26(13):3800. doi: 10.3390/molecules26133800. Molecules. 2021. PMID: 34206470 Free PMC article. Review.